EUR 20 million pharmaceutical supply centre: logistics as critical infrastructure
What modern warehousing, temperature zones, automation and resilient processes must deliver for secure medicine supply.
Read article →Pharma News · Supply availability in Europe
Official notices from Germany, Austria, Belgium, Czechia and Denmark, clearly structured and identified by country.
The data comes from the official shortage systems of the relevant national medicines authorities and is identified by country of origin.

What modern warehousing, temperature zones, automation and resilient processes must deliver for secure medicine supply.
Read article →Eight technology trends—from agentic and physical AI to product provenance and decision governance—translated into GDP practice.
Read analysis →What the official price data means for pharmaceutical wholesale, GDP storage, cold chain, packaging and procurement.
Read analysis →Supply shortage · Not specified
Active ingredient: Japanisches-Enzephalitis-Virus, inaktiviert, adsorbiert
Update notification · Other
Active ingredient: Pantoprazol-Natrium-Sesquihydrat
Update notification · Other
Active ingredient: Amitriptylinhydrochlorid
Update notification · Other
Active ingredient: Telmisartan
Update notification · Other
Active ingredient: Amitriptylinhydrochlorid
Initial notification · Other
Active ingredient: Trandolapril; Verapamilhydrochlorid
Update notification · Other
Active ingredient: Amitriptylinhydrochlorid
Update notification · Other
Active ingredient: Amitriptylinhydrochlorid
Update notification · Other
Active ingredient: Pantoprazol-Natrium-Sesquihydrat
Initial notification · Production problem
Active ingredient: Sevelamer
Update notification · Production problem
Active ingredient: Olanzapinembonat-Monohydrat
Initial notification · Production problem
Active ingredient: Natriumhydrogencarbonat
Update notification · Other
Active ingredient: Adalimumab
Update notification · Production problem
Active ingredient: Iohexol
Update notification · Production problem
Active ingredient: Iodixanol
Update notification · Other
Active ingredient: Iodixanol
Update notification · Other
Active ingredient: Fampridin
Initial notification · Other
Active ingredient: Urapidil
Update notification · Production problem
Active ingredient: Avalglucosidase alfa
Initial notification · Other
Active ingredient: Clarithromycinlactobionat
Initial notification · Production problem
Active ingredient: Dihydrocodein[(R,R)-tartrat]
Update notification · Production problem
Active ingredient: Entecavir
Update notification · Other
Active ingredient: Fluoxetinhydrochlorid
Initial notification · Other
Active ingredient: Prednisolon
Initial notification · Other
Active ingredient: Prednicarbat
Initial notification · Other
Active ingredient: Triamteren; Xipamid
Supply shortage · Not specified
Active ingredient: Diphtherie-, Tetanus-, Pertussis- und Poliomyelitis-Impfstoff
Unavailable · Delivery delay
Active ingredient: Diosmin
Unavailable · Increased demand
Active ingredient: Epinephrin
Unavailable · Delivery delay
Active ingredient: Gabapentin
Limited availability · Delivery delay
Active ingredient: Tranexamsäure
Unavailable · Increased demand
Active ingredient: Raltegravir
Limited availability · Delivery delay
Active ingredient: Propafenonhydrochlorid
Unavailable · Distribution restriction
Active ingredient: Diclofenac; Orphenadrin
Unavailable · Distribution restriction
Active ingredient: Diclofenac
Unavailable · Not specified
Active ingredient: Bariumsulfat
Unavailable · Not specified
Active ingredient: Lisdexamfetamin
Unavailable · Not specified
Active ingredient: Vancomycin
Interruption of marketing · Manufacturing reasons
Active ingredient: Lebensmittel für besondere medizinische Zwecke
Interruption of marketing · Capacity/distribution reasons; according to SÚKL, no substitute is available
Active ingredient: Natriumglycerophosphat
Limited availability · Limited market availability
Active ingredient: Tamoxifen
Supply shortage · Production problems
Active ingredient: Nafarelin (Nafarelinacetat)
Supply shortage · Production problems
Active ingredient: Alirocumab